Method and apparatus for preparing inhibitable vaccine for prevention of stability bacterial disease including protected serum form of new streptococcus paraberis
KR20180106345A
Bacteriophage s8 and the use thereof
KR20180087937A
The composition of the enterotoxigenic Escherichia coli ghost vaccine candidate by recombinant P22 lysozyme-PMAP36 fusion protein against neonatal piglet colibacillosis
KR20180065718A
novel streptococcus strain inactivated vaccine against bacterial diseases in starry flounder using the streptococcus strain
KR101225564B1
A vector for expressing fc domain of canine igg on the cell surface, a host cell transformed with said vector and a method for manufaturing vaccine against canine diseases using said host cell
ZA201107399B
Method and compositions for treatment of cancer
KR101030792B1
Surface expression vector for porcine circovirus type 2 gene and salmonella vaccine transformed by therof
CA2719766A1
Method and compositions for treatment of cancer
KR20090096984A
A vector for cell surface expression of poultry igg fc domain, a host cell transformed with the vector and a manufacturing method of vaccine against viruses related to poultry diseases using the host cell
KR20090083195A
A vector for cell surface expression of bovine igg fc domian, a host cell transformed with the vector and a manufacturing method of vaccine against viruses related to bovine diseases using the host cell
KR20090063690A
An adjuvant comprising inactivated cells expressing immunoglobulin g fc region, a manufacturing method thereof and a method increasing immunity using the same
KR20090030965A
A vector for cell surface expression of pig igg fc domian, a host cell transformed with the vector and a manufacturing method of vaccine against viruses related to pig diseases using the host cell
EP1721615A1
Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
WO2006104292A1
Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts
TW200540273A
Canine distemper virus isolated in korea and recombinant vaccine using the same
KR20060062832A
Recombinant protein, vaccine and prevention method for pmws using the same
KR20060019887A
Live attenuated mixture vaccine for canine distemper in korea
KR20060019886A
Antigenic materials of porcine circovirus type 2 for postweaning multisystemic wasting syndrome
KR20040080382A
Canine distemper virus isolated in korea and recombinant vaccine using the same
KR20050001480A
PROPHYLACTIC VACCINE AGAINST Erysipelothrix rhusiopathiae AND COMBINED VACCINE THEREOF
